STATUTORY RULES.
1962. No. 101.
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1961.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1961.
Dated this thirteenth
day of October 1962.
DE L'ISLE
Governor-General.
By His Excellency's Command,
(SGD.) H.W. WADE
Minister of State for Health.
Amendments of the National Health (Pharmaceutical Benefits)
Regulations. †
Commencement.
1. These Regulations shall come into operation on the first day of November, 1962.
First, Second, Third, Fourth, and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
First Schedule.
Regulation 10.
DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS, OR USED IN, PHARMACEUTICAL BENEFITS EXCEPT AS SPECIALLY PROVIDED.
Absorbable Gelatin Sponge.
Acetazolamide.
Acetomenaphthone.
Adrenaline Acid Tartrate.
Alcohol.
Amethocaine Hydrochloride.
Amethocaine Injection.
Amodiaquine Hydrochloride.
Amphetamine.
Amphetamine Sulphate.
Amylobarbitone.
Amylobarbitone Sodium.
Amylobarbitone Sodium Tablets.
Antimony Potassium Tartrate.
*Notified in the Commonwealth Gazette on 31 October 1962.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; and 1962, No. 34.
8055/62.—Price1s. 10/10.10.1962.
First Schedule—continued.
Antimony Sodium Tartrate.
Antimony Sodium Tartrate Injection.
Apomorphine Hydrochloride.
Apomorphine Injection.
Azovan Blue.
Bacillus Calmette-Guerin Vaccine.
Bacitracin.
Bemegride.
Benzhexol Hydrochloride.
Bismuth Oxychloride.
Bismuth Oxychloride Injection.
Bismuth Sodium Tartrate.
Busulphan.
Butobarbitone.
Calciferol.
Camphor Water.
Caraway.
Carbachol.
Carbimazole.
Carbon Dioxide.
Cardamom Fruit.
Catgut, sterilized surgical.
Cellulose Oxidized.
Chlorcyclizine Hydrochloride.
Chorionic Gonadotropin.
Chloroquine Phosphate.
Chloroquine Sulphate.
Chlorothiazide.
Chloroxylenol.
Chlortetracycline Injection.
Cinchocaine Hydrochloride.
Cinnamon.
Cochineal.
Cod Liver Oil.
Colchicine.
Colchicum Corm.
Coriander.
Corticotrophin.
Cresol.
Cyanocobalamin.
Cyclobarbitone.
Cyclopropane.
Dapsone.
Dexamphetamine Sulphate.
Dextran Injection.
Dextran Sulphate.
Dextran Sulphate Injection.
Dick Control.
Dick Test Toxin.
Diethylcarbamazine Citrate.
Digitalis Leaf.
Dimercaprol.
Diodone Injection.
Diphtheria and Pertussis Vaccine.
Dithranol.
Emetine and Bismuth Iodide.
Emetine Hydrochloride.
Ergometrine Maleate.
Ether Vinyl.
Ethinyloestradiol.
Ethisterone.
Ethopropazine Hydrochloride.
Ethyl Biscoumacetate.
Ethyl Chloride.
Ethylenediamine Hydrate.
Ethyl Oleate.
Gallamine Triethiodide.
Gallamine Injection.
Gentian.
Gentian Compound Infusion.
Ginger.
Halothane.
Hamamelis.
Helium.
Heparin.
Hexamethonium Tartrate.
Histamine Acid Phosphate.
Human Blood, whole.
Human Red Blood Corpuscles, concentrated.
Human Fibrin Foam.
Human Fibrinogen.
Human Gamma Globulin.
Human Gamma Globulin Injection.
Human Serum, dried.
Human Serum, liquid.
Human Plasma, dried.
Human Thrombin.
Hydrocortisone Acetate Ointment.
Hydrocortisone Hydrogen Succinate.
Hydrocortisone Ointment.
Hydrogen Peroxide Solution, strong.
Hydroxychloroquine Sulphate.
Hyoscine Eye Ointment.
Hyoscyamus.
Indigo Carmine.
Iodised Oil Injection.
Iodoxyl.
Iopanoic Acid.
Iopanoic Acid Tablets.
Ipecacuanha.
Ipecacuanha, prepared.
Isoniazid.
Lead Acetate.
Lead Monoxide.
Lemon Peel, dried.
Lemon Peel, fresh.
Leptazol.
Lignocaine and Adrenaline Injection.
Lignocaine Hydrochloride.
Lignocaine Hydrochloride Injection.
Liothyronine Sodium.
Liothyronine Tablets.
Lucanthone Hydrochloride.
Male Fern.
Male Fern Extract.
Maleic Acid.
Mannitol.
Mepacrine Hydrochloride.
Mephenesin.
Mephenesin Injection.
Mercaptofurine.
Mercuric Oxide, yellow.
Mercury.
Mersalyl Acid.
Methadone Hydrochloride.
First Schedule—continued.
Methoin.
Methyltestoserone.
Methylamphetamine Hydrochloride.
Methylthiouracil.
Mustine Hydrochloride.
Nalorphine Hydrobromide.
Naphazoline Hydrochloride.
Neostigmine Bromide.
Neostigmine Methylsulphate.
Nicotinic Acid.
Nikethamide.
Nitrous Oxide.
Nux Vomica.
Oestradiol Benzoate.
Opium.
Opium, powdered.
Orange Peel, dried bitter.
Orange Peel, fresh bitter.
Ouabain.
Oxygen.
Oxytetracycline Dihydrate.
Paramethadione.
Pentamidine Injection.
Pentamidine Isethionate.
Pethidine Tablets.
Phenindamine Tartrate.
Phenindione.
Pheniodol.
Phenolphthalein Tablets.
Phenolsulphonphthalein.
Phytomenadione.
Phytomenadione Capsules.
Picrotoxin.
Poliomyelitis Vaccine.
Potassium Perchlorate.
Prednisone Acetate.
Primaquine Phosphate.
Primidone.
Probenecid.
Procyclidine Hydrochloride.
Procaine and Adrenaline Injection,
Progesterone.
Proguanil Hydrochloride.
Propyliodone.
Propyliodone Injection.
Propyliodone Oily Injection.
Propyl Thirouracil
Pyridostigmine Bromide.
Pyrimethamine.
Pyrimethamine Tablets.
Quillaia.
Senna Leaf.
Sesame Oil.
Soda Lime.
Sodium Aminosalicylate Tablets.
Sodium Antimonylgluconate.
Sodium Antimonylgluconate Injection.
Sodium Aurothiomalate.
Sodium Radio-iodido (181I) Injection.
Sodium. Radio-iodido (181I) Solution.
Sodium. Radiophosphate (88P) Injection.
Sodium Radiophosphate (82P) Solution.
Sodium Stibogluconate.
Sodium Stibogluconate Injection.
Solapsone.
Solapsono Tablets.
Stibophen.
Stramonium Dry Extract.
Sulphadimidine Sodium.
Suramin.
Suxamethonium Bromide.
Suxamethonium Chloride.
Suxamethonium Chloride Injection.
Testosterone.
Tetrachloroethylene.
Thiomersal.
Thiopentone Sodium.
Thiopentone Injection.
Thyroid.
Thyroxine Sodium.
Tolazoline Hydrochloride.
Tolbutamide.
Trichloroethylene.
Tryparsamide.
Tuberculin, old.
Tuberculin Purified Protein Derivative.
Tubocurarine Chloride.
Tubocurarine Injection.
Typhoid-Paratyphoid A and B and Cholera Vaccine.
Typhoid-Paratyphoid A and B tetanus Vaccine.
Yellow Fever Vaccine.
Second Schedule.
Regulation 10(3).
DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Dried Aluminium Hydroxide Gel. B.P..... | Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
| Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
| Dried Aluminium Hydroxide Gel. B.P. with Magnesium Carbonate B.P. |
Aluminium Hydroxide Gel. B.P......... | Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P. |
| Aluminium Hydroxide Gel. B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P. |
| Aluminium Hydroxide Gel. B.P. with Kaolin Light B.P. and Pectin |
| Aluminium Hydroxide Gel. B.P. with Magnesium Hydroxide |
| Aluminium Hydroxide Gel. with Magnesium Trisilicate B.P. |
Aluminium Powder ................. | Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P. |
Amiphenazole Hydrobromide .......... | — |
Amiphenazole Hydrochloride A.P.F. 1955 | — |
Aneurine Hydrochloride B.P. .......... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Ascorbic Acid B.P. ................. | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Bendrofluazide .................... | — |
Benethamine Penicillin ............... | Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P. |
Benzalkomum Chloride .............. | — |
Benzathine Penicillin B.P. ............. | Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P. |
Benzylpenicillin B.P. ................ | Fortified Procaine Penicillin Injection B.P. |
| Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
| Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P. |
Benzylpenicillin Sodium B.P........... | Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P. |
| Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P. |
Betamethasone Phosphate ............. | — |
Bismuth Subnitrate B.P.C. ............ | Resorcinol B.P. with Bismuth Subnitrate B.P.C. Zinc Oxide B.P., Starch B.P., Cade Oil B.P. Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P. |
Butabarbital Sodium................. | — |
Carbromal B.P..................... | Pentobarbitone Sodium B.P. with Carbromal B.P. |
Chloramphenicol B.P. ............... | Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water |
| Chloramphenicol B.P. with Propylene Glycol B.P. |
| Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Second Schedule—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Chlorhexidine Diacetale.............. | — |
Chlorpromazine Hydrochloride B.P. ...... | — |
Chlortetracycline Calcium ............ | — |
Chlortetrycline Hydrochloride B.P. ....... | Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Clemizole ....................... | — |
Cortisone Acetate B.P. ............... | — |
Demethylchlortetracycline Hydrochloride... | — |
Dexamethasone Sodium Phosphate ....... | — |
Dextrochlorpheniramine Maleate ........ | — |
Dicyclomine Hydrochloride ........... | — |
Dienoestrol B.P. ................... | — |
Diethyl Dithiolisophthalate ............ | — |
Diiodohydroxyquinoline B.P. .......... | — |
Diphtheria Vaccine B.P. .............. | Diphtheria, Tetanus and Pertussis Vaccine B.P. Diphtheria and Tetanus Vaccine B.P. |
Diphtheria and Tetanus Vaccine B.P ...... | — |
Ergotamine Tartrate B.P. ............. | Ergotamine Tartrate B.P. with Caffeine B.P. |
| Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. and Diphenhydramine Hydrochloride B.P. |
| Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P. |
Erythromycin B.P. .................. | — |
Ethotoin ........................ | — |
Ferrous Aminoacetosulphate ........... | — |
Ferrous Succinate .................. | — |
Glucose Indicator .................. | — |
Gramicidin ...................... | Gramicidin with Polymyxin B. Sulphate B.P. and Neomycin Sulphate B.P. |
Griscofulvin ...................... | — |
Guanethidine Sodium ................ | — |
Haemophilus Influenza Bacterial Serum.... | — |
Hamamclis Dry Extract .............. | Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P. |
Hexocyclium Methyl Sulphate .......... | — |
Hydrocortisone B.P. ................ | — |
Hydrocortisone Acetate B.P. ........... | Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. |
Hydrocortisone Sodium Succinate ....... | — |
Isoprenaline Hydrochloride ............ | — |
Isopropamide Iodide ................ | — |
Levallorphan Tartrate .................. | Levallorphan Tartrate with Pethidine Hydrochloride B.P. |
Lofenalac ....................... | — |
Meclozine Hydrochloride B.P.C. ........ | — |
Mercuric Oxide Eye Ointment B.P....... | — |
Methazolamide .................... | — |
Methscopolamine Bromide ............ | — |
Methyclothiazide .................. | — |
Methylphenobarbitone B.P.C. .......... | — |
Methylprednisolone ................. | — |
Minafen ........................ | — |
Naphazoline Nitrate B.P. ............. | Antazoline Hydrocloride B.P. with Naphazoline Nitrate B.P. |
Neomycin Sulphate B.P., Eye Drops ...... | Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base |
| Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P. |
| Neomycin Sulphate B.P. with Polymyxin B. Sulphate B.P. and Gramicidin |
Second Schedule—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Nicotinamide B.P................... | Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Oestrone ........................ | — |
Oleandomycin .................... | Tetracycline with Oleandomycin |
Oleoresin Capsicum ................. | Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum |
Oxyphencyclimine Hydrochloride ....... | — |
Oxyphenonium Bromide ............. | — |
Oxytetracycline Hydrochloride B.P. ...... | Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Papaveretum B.P.C. ................. | Papaveretum B.P.C. with Hyoscine Hydrobromide B.P. |
Pancreatin B.P. .................... | — |
Pempidine Tartrate ................. | — |
Pentolinium Tartrate B.P. ............. | Pentolinium Tartrate B.P. with Ephedrine B.P. |
Pethidiue Hydrochloride B.P. .......... | Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P. |
| Pethidine Hydrochloride B.P. with Levallorphan Tartrate |
Pertussis Vaccine B.P. ............... | Diphtheria, Tetanus and Pertussis Vaccine B.P. Diphtheria and Pertussis Vaccine B.P. |
Phenoxymethylpenicillin B.P. .......... | — |
Phenoxymethylpenicillin (Benzathine Salt).. | — |
Phenoxymethylpenicillin Calcium B.P..... | — |
Phenoxymethylpenicillin (Hydrabamine Salt) | — |
Phenoxymethylpenicillin Potassium B.P.... | — |
Pipenzolatc ...................... | — |
Polydimethylsiloxanes ............... | — |
Polymyxin B. Sulphate B.P. ........... | Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base |
| Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer |
| Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P. |
| Polymyxin B. Sulphate B.P. with Tetracycline Hydrochloride |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
Prednisolone B.P. .................. | Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. R.P. |
| Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Prednisolone Disodium Phosphate ....... | — |
Prednisone B.P. ................... | Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
Procaine Hydrochloride B.P. ........... | Procaine Hydrochloride B.P. in Normal Saline Tetracycline and Procaine Injection B.P. |
Pyrazinamide ..................... | — |
Pyridine Aldozime Methiodide ......... | — |
Pyrimido-Pyrimidine ................ | — |
Pyrrolidino-Mcthyl-Tetracycline ........ | — |
Second Schedule—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Rauwolfia Alkaloids ................ | — |
Reserpine B.P. .................... | — |
Riboflavine B.P. ................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Sobee .......................... | — |
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydratcd Calcium Chloride B.P. in Water for Injection B.P. | Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P. |
Compound Sodium Lactate Injection B.P.... | Compound Sodium Lactate Injection B.P. with Dextrose B.P. |
Sodium Lauryl Sulphate B.P. ........... | Emulsifying Wax B.P. |
Streptomycin Sulphate B.P. ............ | Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
| Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P. |
| Streptomycin Sulphate B.P., with Normal Saline |
Sulphadimidine B.P. ................ | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P. |
Sulphamerazine B.P................. | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P. |
| Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole |
| Sulphadiazine B.P. with Sulphamerazine B.P. and Sulnhacetamide |
Sulphacetamide ................... | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide |
Sulphathiazole .................... | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole |
Tacrine ......................... | Tacrine with Morphine |
Terpineol B.P. .................... | Solution of Chloroxylenol B.P. |
Tetanus Vaccine B.P. ................ | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Tetracycline Hydrochloride B.P. ........ | Tetracycline Hydrochloride B.P. with Nystatin |
| Tetracycline and Procaine Injection B.P. |
| Tetracycline Hydrochloride B.P. with a buffering agent |
| Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Tetracycline ...................... | Tetracycline with Oleandomycin |
Thenalidine ...................... | Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P. |
Theobroma Prepared B.P.C. ........... | Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C. |
Triamcinolone .................... | — |
Trifluoperazine .................... | — |
Tricyclamol Chloride ................ | — |
Tripelennamine Hydrochloride ......... | — |
Troxidone B.P. .................... | — |
Typhoid Para-Typhoid A and B Vaccine B.P. | Typhoid Para-Typhoid A, B and C Vaccine B.P. |
Viprynium Embonate ................ | — |
Concentrated Vitamin A Solution B.P...... | Concentrated Vitamins A and D Solution B.P. |
Concentrated Vitamin D Solution B.P...... | Concentrated Vitamins A and D Solution B.P. |
Vitamin D ....................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Yellow Mercuric Oxide B.P. ........... | Mercuric Oxide Eye Ointment B.P. |
Third Schedule.
Regulation 11.
PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPEIA.
Acetazolamide Sodium.
Acetyl-Sulphamethoxypridazine.
Aconite Liniment, B.P.C.
Acriflavine, B.P. 1948.
Acrylic Resin.
Adrenaline Hydrochloride Solution, B.P. 1953.
Adrenaline Mucate.
Agar, B.P.C.
Aloes Pill, B.P. 1948.
Aloin, B.P. 1953.
Aloxidone.
Aluminium Acetate Solution, B.P.C.
Aluminium Powder.
Amaranth Solution, A.P.F.
Amaranth Solution, B.P.C. 1954
Amidopyrin, B.P.C. 1954.
Amiphenazole Hydrobromide.
Amiphenazole Hydrochloride, A.P.F. 1955.
Ammonium Acetate, Strong Solution, B.P. 1953.
Ammonium Bicarbonate, B.P. 1953.
Ammonium Bromide, B.P.C.
Amphotericin B.
Androstanolone.
Aniseed Water, concentrated, B.P.C.
Aniseed Spirit, B.P.C. 1949.
Aromatic Ammonia Spirit, B.P. 1953.
Aurothioglucose.
Balsam of Peru, B.P.C.
Beeswax, Yellow, B.P.C.
Belladonna Suppository, B.P. 1948.
Bendrofluazide.
Benzalkonium Chloride.
Benzoinated Lard, B.P.C. 1954.
Benzol (Commercial).
Benzylpenicillin in Oil.
Bephenium Hydroxynaphthoate.
Betamethasone.
Betamethasone Phosphate.
Bismuth Carbonate, B.P. 1953.
Bismuth Glycollylarsanilate.
Bismuth Subgallate, B.P.C.
Bismuth Subnitrate, B.P.C.
Bretylium Tosylate.
Brown Snake Antivenene.
Buchu Concentrated Infusion, B.P.C. 1954.
Butabarbital Sodium.
Butyl Aminobenzoate, B.P. 1953.
Caffeine Citrate, B.P.C.
Cajuput Spirit, B.P. 1948.
Calamine Cream, A.P.F.
Calcium Aurothiomalate.
Calcium Di-Oxytetracycline.
Calcium Aminosalicylate, B.P.C.
Calcium Phosphate, B.P. 1953.
Caluma Concentrated Infusion, B.P. 1948.
Calumba Tincture, B.P. 1948.
Camphor Water, concentrated, B.P.C. 1949.
Capsicum Ointment, B.P.C.
Capsicum Tincture, B.P.C.
Caramiphen Hydrochloride.
Caraway Oil, B.P.C.
Carbinoxamine Maleate.
Cardamom Aromatic Tincture, B.P.C.
Carmine Solution, A.P.F.
Catechu Tincture, B.P.C.
Cetyl Alcohol Compound.
Charcoal.
Chlorambucil.
Chloramine, B.P.C.
Chlorazanil.
Chlorhexidine Diacctate.
Chlormerodrin.
Chlorobenzol Disulphonamide.
Chloroform Water, concentrated, B.P.C.
Chlorpheniramine Maleate.
Chlorpropamide.
Chlortetracyline Calcium.
Chlorthalidone.
Spirit of Cinnamon, B.P.C. 1949.
Clemizole Hydrochloride.
Clemizole Tannate Syrup.
Cloves, Concentrated Infusion, B.P.C. 1954.
Cochineal Tincture, 1948.
Coconut Oil, B.P.C. 1949.
Codeine, B.P.C. 1954.
Cod Liver Oil Emulsion, B.P., 1953.
Colchicine Salicylate.
Colocynth and Hyoscyamus Pill, B.P.C.
Colocynth, B.P.C.
Compound Effervescent Powder, B.P. 1953.
Creosote, B.P. 1953.
Crude Coal Tar.
Cudbear Tincture, A.P.F. 1947.
Cyclopenthiazide.
Cyclophosphamide.
Cycloserine.
Cycrimine Hydrochloride.
Cymogran.
Cyproheptadine.
Darrow's Solution.
Death Adder Antivenene.
Demecarium Bromide.
Demethylchlortctracycline Hydrochloride.
Desacetyl-Lanatoside, C.
Dexamethasone.
Dexametliasone Sodium Phosphate.
Dextran Iron.
Dextrin Iron.
Dextrochlorpheniramine Maleate.
Dichlorphenamide.
Dicyclomine Hydrochloride.
Diethazine Hydrochloride.
Diethyl Dithiolisophthalate.
Third Schedule—continued.
Diloxanide Furoate.
Digitoxin, B.P.C.
Dihydroergotamine.
Dihydromorphinone Hydrochloride, B.P.C. 1949.
Diphenylpyraline Hydrochloride.
Diphtheria Toxoid Purified.
Disodium Diethylstilboestrol Diphosphate.
Disodium Dihydrogen Versenate.
Dithiazanine Iodide.
Dyflos, B.P.C.
Ecothiopate Iodide.
Ephedrine Sulphate, B.P.C. 1954.
Ergot Liquid Extract, B.P.C. 1954.
Erythrityltetranitrate, B.P.C. 1949.
Erythromycin Glucoheptonate.
Erythromycin Propionate.
Erythromycin Stearate.
Ethionamide.
Ethosuximide.
Ethotoin.
Ethoxzolamide.
Etlylidene Dicoumarin.
Ethylnoradrenaline.
Ferric Hydroxide.
Ferric Chloride Solution, B.P.C.
Ferrous Aminoacetosulphate.
Ferrous Phosphate Compound Syrup, B.P.C.
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.
Ferrous Succinate.
Fludrocortisone Acetate.
Fluoxymesterone.
Formyl-Tetrahydropteroyl Glutamic Acid.
Fructose, B.P. 1948.
Gall with Opium Ointment, B.P.C.
Gelsemium Tintcure, B.P.C.
Gentian Violet.
Glucagon Hydrochloride.
Glucose Indicator.
Glucose Liquid, B.P. 1953.
Glutethimide, B.P.C.
Glycerophosphates Compound Syrup, A.P.F.
Gramicidin.
Griseofulvin.
Guanethidine Sodium.
Guanethidine Sulphate.
Haemophilus Influenza Bacterial Serum.
Hamamelis Dry Extract.
Heparin Retard.
Hexachlorophene, 3% with Entsufon.
Hexachlorophene, 3% with Lissapol.
Hexachlorophene, 1.5% with Soap Solution.
Hexachlorothiazide.
Hexocyclium Methyl Sulphate.
Hexoestrol.
Honey, Purified, B.P.C.
Hydrocalciferol.
Hydrocyanic Acid Dilute, B.P.C. 1954.
Hydroflumethiazide.
Hypophosphorous Acid Dilute, B.P.C.
Insulin Isophone (N.P.H.).
Insulin Special P (Pig).
Iodochlorhydroxyquinoline.
Iodoform B.P.C.
Iodoform Suppository, B.P. 1948.
Ipomoca Rosin.
Iron Aminote.
Iron Carbonate Saccharated, B.P.C.
Iron Oxide Saccharated.
Iron Carbohydrate Complex.
Iron Phosphate Compound Syrup, B.P.C.
Isoprenaline Hydrochloride.
Isopropamide Iodide.
Isothipendyl Hydrochloride.
Kanamycin Sulphate.
Lavender Oil, Spike, B.P.C.
Lemon Syrup, neutral, A.P.F.
Levallorphan Tartrate.
Levorphanol Tartrate, B.P.C.
Lissapol, N 100.
Lobelia Ethereal Tincture, B.P.C.
Lofenalac.
Magenta, B.P.C.
Magnesium Bicarbonate Solution, B.P. 1948.
Mebhydrolin.
Mecamylamine.
Mecholyl Chloride.
Meclozine Hydrochloride, B.P.C.
Mephentermine Sulphate.
Mercaptomerin Sodium.
Mercuric Chloride, B.P. 1953.
Mercurous Chloride Ointment, B.P. 1948.
Mercury Compound Ointment, B.P.C.
Methazolamide.
Methenamine Mandelate.
Methenolone Oenanthate.
Methicillin.
Methotrexate.
Methscopolamine Bromide.
Methyclothiazide.
Methyl Androstanolone.
Methyl Atropine Nitrate.
Methylcellulose, A.P.F.
Methylcellulose Mucilage, A.P.F.
Methyl Prednisolone.
Methyl Prednisolone Acetate.
Methylandrostenediol.
Methylphenobarbitone, B.P.C.
Metronidazole.
Minafen.
Myrrh, B.P.C.
Myrrh Tincture, B.P.C.
Nandrolone.
Nicoumalone.
Nitrofurantoin.
Nitromin.
Nitrous Ether Spirit, B.P.C.
Norethandrolone
Nux Vomica Extract, Dried, B.P. 1953.
Nystatin.
Oestradiol Dipropionate.
Oestrone.
Third Schedule—continued.
Oleandomycin.
Oleoresin Capsicum.
Orange Peel Infusion Concentrated, B.P. 1948.
Orange Peel Infusion Concentrated, Compound, B.P.C.
Ox-Bile Extract, B.P. 1948.
Oxymel, B.P.C.
Oxymel of Squill, B.P.C.
Oxyphencyclimine Hydrochloride.
Oxyphenonium Bromide.
Pancreatin 4, U.S.N.F. XI.
Para-Aminosalicyclic Acid.
Paraben Ophthalmic Phosphate Buffer, A.P.F.
Paraben Ophthalmic, Vehicle, A.P.F.
Paracetamol.
Paramethasone Acetate.
Papaveretum, B.P.C.
Pectin.
Pempidine Tartrate.
Penicillin Benethamine.
Penicillinase.
Pentaerythritol Tetranitrate.
Penthienate.
Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed).
Phenazone, B.P.C.
Phenazopyradine Hydrochloride.
Phenethicillin.
Phenformin.
Phenoxymethylpenicillin (Benzathine Salt).
Phenoxymethylpenicillin (Hydrabamine Salt).
Phensuximide.
Phenylbutazone.
Phenylmercuric Dinaphthylmethane Disulphonate.
Phenytoin.
Pholcodine, B.P.C.
Pholcodine Citrate Syrup, B P C.
Phthalylsulphacetamide.
Physostigmine Alkaloid.
Pipenzolate.
Pituitary (Posterior Lobe).
Polydimethylsiloxanes.
Potash Sulphurated, B.P.C.
Potassium Chlorate, B.P.C.
Prednisolone Disodium Phosphate.
Prednisolone Sodium Hemisuccinate.
Prednisolone Trimethylacetate.
Prophenpyridamine Maleate.
Prophenpyridamine Para-Aminosalicylate.
Propylthiouracil B.P.C.
Protamine Sulphate.
Protoveratrines A.
Pyrazinamide.
Pyridine Aldoxine Methiodide.
Pyrrolidino-Methyl-Tetracycline.
Quillaia Tincture, B.P.C.
Rauwolfia Alkaloids.
Red Back Spider Antivenene.
Red Syrup.
Ristocetin.
Salicylamide.
Salicylazosulphapyridine.
Senega Concentrated Infusion, B.P.C.
Senna Compound Mixture, B.P.C.
Senna Fruit Extract.
Senna Loaf Concentrated Infusion, B.P.C.
Siberian Fir Oil, B.P.C. 1949.
Silver Picrate, B.P.C. 1949.
Silver Protein Mild, B.P.C.
Soap Curd, B.P.C.
Soap, Hard, B.P.C.
Sobee.
Sodium Calcium Edetate.
Sodium Carbonate Exsiccated, B.P.C.
Sodium Folate.
Sodium Lactate.
Sodium Nitrite, B.P.C.
Sodium Olcate Acid.
Sodium Tauroglycocholate.
Sorbolene, A.P.F.
Spearmint Oil.
Spiramycin.
Spironolactone.
Squill Syrup, B.P.C.
Squill Tincture.
Squill Vinegar, B.P. 1948.
Stearic Acid, B.P.C.
Strophantus Tincture, B.P. 1948.
Strychnine, B.P.C.
Sulfinpyrazone.
Sulphacetamide.
Sulphadiazine Sodium.
Sulphadimethoxine.
Sulphamethoxydiazine.
Sulphamethoxypyridazine.
Sulphafurazole.
Sulphamethizole.
Sulphaphenazole.
Sulphathiazole.
Sulphapyridine, B.P.C.
Sulphuric Acid Dilute, B.P.C.
Surgical Cement.
Sustanon.
Syntocinon.
Tacrine.
Taipan Antivenene.
Talc Purified, B.P.C.
Testosterone Oenanthate.
Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.
Tetracycline.
Thenalidine Tartrate.
Theobromine, B.P.C.
Theobroma Prepared, B.P.C.
Thiacotazone.
Thiambutosine.
Thyrotrophin.
Tiger Snake Antivenene.
Tretainino.
Triamcinolone.
Third Schedule—continued.
Tricyclamol Chloride.
Triethanolamine, B.P.C.
Triethanolamine Trinitrate.
Triethylene Thiophosphoramide.
Trifluoperazine.
Trimetaphan Camphorsulphonate.
Trinitorphenol, B.P.C.
Triprolidine
Hydrochloride.
Valerian Ammoniated Tincture, B.P.C.
Vancomycin Hydrochloride.
Vasopressin Tannate in Oil.
Veriloid.
Viomycin Sulphate.
Viprynium Embonate.
Vitamin A.
Vitamin D.
Vitamin K.
Volatile Bitter Almond Oil, B.P. 1953.
Warfarin Sodium.
Fourth Schedule.
Regulation 12.
ADDITIVES.
Acetone, B.P.C.
Alcohol, B.P.
Amethocaine Hydrochloride, B.P.
Bacitracin, B.P.
Carmine Solution, A.P.F.
Cod Liver Oil, B.P.
Oil of Caraway, B.P.C.
Oil of Citronella, B.P.C.
Xylene, B.P.C. 1949.
Fifth Schedule.
Regulation 14.
PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Acrylic Resin ..................... | Ileostomy or colostomy conditions |
Amiphenazole Hydrobromide......... | As an antidote to barbiturate and other hypnotic poisons |
Amiphenazole Hydrochloride A.P.F. 1955 | |
Amphotericin B ................... | Systemic fungal infections |
Androstanolone ................... | Mammary carcinoma |
Aneurine Hydrochloride Tablets B.P...... | Any disease or condition in a pensioner |
Ascorbic Acid Tablets B.P. ............ | Any disease or condition in a pensioner |
Bemegride Injection B.P.............. | As an antidote to barbiturate and other hypnotic poisons |
Benzol (Commercial) ................ | Ileostomy or colostomy conditions |
Betamethasone .................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Busulphan Tablets B.P. .............. | The leukaemias |
Calciferol Tablets B.P................ | Any disease or condition in a pensioner |
| With the written authority of the Director-General, idiopathic hypoparathyroidism |
Calciferol Solution B.P................ | Any disease or condition in a child under the age of twelve years or in a pensioner |
Calcium Para-Aminosalicylatc B.P.C...... | Tuberculosis |
Caramiphen Hydrochloride ............ | Parkinsonism |
Chlorambucil ..................... | Malignant lymphoma and related conditions |
Chloraminc B.P.C., Tablets or Powder | Ileostomy or colostomy conditions |
Chloramphenicol Capsules B.P. ......... | Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate |
| Bacterium coli meningitis, if other forms of treatment are unsuccessful |
| Brucellosis |
| Granuloma inguinale |
| Friedlander bacillus infections |
| Haemophilus influenza infections |
| Laryngo-trachco-bronchitis, acute |
| Lymphogranuloma venereum |
| Pre-operative prophylaxis |
| Salmonella infections |
| Staphylococcal infections |
| Surgical conditions of the bowel (pre-operative and post-operative) |
| Typhoid fever |
| Typhus and other rickettsial diseases |
| Urinary tract infections duo to gram negative bacilli that arc resistant to the Sulphonamides |
| Whooping cough (Haemophilus pertussis) |
| As an alternative to the Penicillins in a person sensitive to the Penicillins |
| Severe gastro-enteritis in a child under the age of sixteen years |
Chloramphenicol B.P., Injection......... | A disease or condition specified in this column in relation to Chloramphenicol Capsules |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Chloramphenicol B.P., Oral Suspension.... | A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years |
Chlorpheniramine Maleate Oral Linctus.... | Any disease or condition in a child under the age of twelve years |
Chlorpromazine Hydrochloride B.P. ...... | Any disease or condition in a pensioner |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride or Trifluoperazine |
Chlortetracycline Capsules B.P. ......... | As an alternative to the Penicillins in a person sensitive to the Penicillins |
| Actinomycosis |
| Amoebiasis |
| Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute |
| Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate |
| Bronchiectasis |
| Brucellosis |
| Chancroid |
| Fibrocystic disease of the pancreas |
| Granuloma inguinale |
| Friedlander bacillus infections |
| Leptospirosis |
| Lymphogranuloma venereum |
| Mucoviscidosis |
| Pneumonia that is resistant both to the Penicillins and the Sulphonamides |
| Pre-operative prophylaxis |
| Primary atypical pneumonia |
| Psittacosis |
| Puerperal infections |
| Rat-bite fever (Spirillum minus) |
| Staphylococcal infections |
| Trachoma that is resistant to the Sulphonamides |
| Typhus and other rickettsial diseases |
| Urinary tract infections duo to gram negative bacilli that are resistant to the Sulphonamides |
| Whooping cough (Haemophilus pertussis) |
Chlortetracycline Calcium .......... | A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years |
Chlortetracycline B.P. Granules....... |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Clemizole Tannate Syrup ............. | Any disease or condition in a child under the age of twelve years |
Cod Liver Oil, B.P.............. | Any disease or condition in a child under the age of twelve years or in a pensioner |
Cod Liver Oil Emulsion B.P. 1953.... | |
Corticotrphin Injection B.P............. | With the written authority of the Director-General— |
Corticotrophin Gelatin Injection B.P.... | A disease or condition specified in this column in relation to Cortisone Injection |
Cortitrophin Zinc Hydroxide Injection B.P. | The treatment of side effects of corticosteroid therapy |
Cortisone Injection B.P. .............. | With the written authority of the Director-General— |
| Anaemia, acquired haemolytic |
| Addison's disease and other forms of adrenocortical hypoplasia |
| Adrenalectomy, total |
| Adrenogenital syndrome |
| Cranial arteritis |
| Cushing's syndrome, including hyperadrenocorticalism |
| Dermatitis, acute exfoliotive, associated with drug therapy |
| Dermatomyositis |
| Encephalomyelitis |
| Guillain-Barre syndrome |
| Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis |
| Hansen's disease |
| Hepatitis, progressive or continuing, proven by biopsy or biochemistry |
| Hodgkin's disease |
| Idiopathic hypercalcaemia |
| Keratoplasty |
| The leukaemias |
| Lymphosarcoma and follicular lymphoma |
| Metastatic breast carcinoma |
| Nephritis, type II. |
| Nephrosis or nephrotic syndrome |
| Neuro-myelitis optica |
| Optic neuritis following removal of tumor of the brain |
| Panhypopituitarism |
| Pemphigus |
| Periarteritis nodosa |
| Progressive transverse myelitis |
| Pseudohermaphroditism |
| Purpura, Henoch's |
| Purpura, thrombocytopenic |
| Reticulum cell sarcoma |
| Rheumatic carditis, acute |
| Salaam convulsions and hypsarrythmia |
| Sarcoidosis |
| Scleroderma |
| Severe reactions of the skin and mucosa following X-ray therapy |
| Splenic neutropenia and agranulocytosis |
| Status asthmaticus |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
| Steroid therapy prior to operation in patients under steroid therapy |
| Stevens-Johnson syndrome |
| Still's disease in a child under the age of sixteen years |
| Sympathetic ophthalmitis |
| Systemic lupus erythematosus |
| Temporal arteritis |
| Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases |
| Ulcerative colitis proven by sigmoidoscopy or radiological report |
| Uveitis, posterior |
Cortisone Tablets B.P. ............... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength) | Established megalocytic anaemias |
Cyanocobalamin Injection B.P., 1,000 microgrammc strength | Neuroblastoma |
Cymogran ....................... | With the written authority of the Director-General, phenylketonuria |
Cycloserine ...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Demethylchlortetracycline Hydrochloride... | A disease or condition specified in this column in relation to Chlortetracycline Capsules |
Deoxycortone Acetate B.P. .......... |
|
Deoxycortone Acetate Injection B.P.... | Addison's disease |
Deoxycortone Acetate Implant B.P...... | Total adrenalectomy |
Dexamcthasone ................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Dextrochlory heniramine Maleate Syrup.... | Any disease or condition in a child under the age of twelve years |
Dienocstrol B.P., Cream .............. | Any disease or condition in a pensioner |
Dienoestrol Tablets B.P. .............. | Carcinoma of the prostate
|
| Mammary carcinoma |
| Any disease or condition in a pensioner |
Diethyl Dithiolisophthalate ............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Diiodohydroxyquinoline B.P., Vaginal Tablet | Trichomonal and monilial vaginitis |
Dihydrostreptomycin Sulphate Injection B.P. | As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate |
Diloxanide Furoate ................. | Amoebic dysentery |
Diphenhydramine Hydrochloride B.P., Elixir | Any disease or condition in a child under the age of twelve years |
Disodium Diethylstilboestrol Diphosphate.. | Carcinoma of the prostate |
Erythromycin B.P. .................. |
|
Erythromycin Tablets B.P. ............ | Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins |
Erythromycin Glucoheptonate.......... | |
Erythromycin Propionate ............. |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act. |
Erythromycin B.P., Oral Sachet | Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years |
Erythromycin B.P., Oral Suspension | |
Erythromycin Stearate, Oral Suspension | |
Ethinylocstradiol Tablets B.P. ........ | Turner's syndrome |
| Pre-menopausal castration syndrome |
| Any disease or condition in a pensioner |
Ethionamide ...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Ethisterone Tablets B.P. .............. | Turner's syndrome |
| Habitual abortion |
| Any disease or condition in a pensioner |
Ferric Hydroxide Colloidal Solution | Any disease or condition in a child under the age of twelve years |
Ferrous Aminoacetosulphatc Syrup | |
Ferrous Gluconate Elixir ........... | |
Ferrous Succinate Syrup.............. |
|
Fludrocortisone Acetate .............. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Fluoxymestorone .................. | Mammary carcinoma |
Folic Acid B.P. .................. | Macrocytic anaemia |
Folic Acid Tablets B.P. ............ | Sprue or the sprue-like syndrome |
Formyl-Tetrahydropteroyl Glutamic Acid | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Griseofulvin ...................... | With the written authority of the Director-General— |
| For the treatment of any of the following diseases, the diagnosis of which has been confirmed by pathological report:— |
| Epidermophyton floccosum |
| Microsporum audouni |
| Microsporum canis |
| Microsporum gypseum |
| Trychophyton interdigitale |
| Trichophyton mentagrophytes |
| Trichophyton rubram |
| Trichophyton schoenleini |
| Trichophyton sulphureum |
| Trichophyton verrucosum |
Haemophilus Influenza Bacterial Serum | Any disease or condition in a pattern, receiving treatment in or at an approved hospital
|
Hexachlorophene, 3% with Entsufon | |
Hexachlorophene, 3% with Lissapol | |
Hexachlorophene, 1.5% with Soap Solution | |
Hydrocalciferol .................... | Parathyroid deficiency |
Hydrocortisone Injection B.P. .......... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Hydrocortisone Sodium Succinate B.P. | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report |
Hydrocortisone Sodium Succinate Injection B.P. | Acute adrenal failure due to a medical or surgical crisis |
| Stevens-Johnson syndrome |
Isionazid Tablets B.P. ............... | Hansen's disease |
| Tuberculosis |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be proscribed) for supply under Part VII. of the Act. |
Kanamycin Sulphate ................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Levorphanol Tartrate B.P.C. ........... | Obstetrical use |
| Severe intractable pain |
Lissapol Deodorant Detergent (Lissapol N100 with Spearmint Oil and Cetrimide) | Ileostomy or colostomy condition |
Lofenalac ....................... | With the written authority of the Director-General, phenylketonuria |
Malt Extract B.P. ................. | Any disease or condition in a child under the age of twelve years or in a pensioner |
Malt Extract with Cod Liver Oil B.P. | |
Mcpyramme Maleate Elixir ............ | Any disease or condition in a child under the age of twelve years |
Mercaptopurine Tablets B.P. ........... | Allergic angiitis |
| Periarteritis |
| Systemic lupus erythematosus |
| The leukaemias |
Mcthenolone Oenanthrate ............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Methicillin ....................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Methyl Androstanolone .............. | Mammary carcinoma |
Methylandrostenediol ............... | Senile osteoporosis proven by radiography |
Methyl Prednisolone Acetate ........... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Minafen ........................ | With the written authority of the Director-General, phenylketonuria |
Morphine with Tacrine, 30mg.–15mg. Oral Tablet | Severe intractable pain |
Mustine Injection B.P. ............... | Malignant lymphoma and related conditions |
Nandrolone ...................... | Mammary carcinoma |
Neomycin Sulphate B.P., in a form other than Eye Drops | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Nicotinamide Tablets B.P. ............ | Any disease or condition in a pensioner |
Nicotinic Acid Tablets B.P. ............ | Any disease or Condition in a pensioner |
Nitrofurantoin .................... | Urinary tract infections |
Nitrofurantoin Suspension ............ | Any urinary tract infection in a child under the age of twelve years |
Nitromin ........................ | Malignant lymphoma and related conditions |
Norethandrolone ................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Novobiocin Calcium B.P. ........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Novobiocin Sodium B.P. ........... | |
Novobiocin Tablets B.P. ............ | |
Nystatin ........................ | Proven monilia infections |
Oxytetracycline Tablets B.P. | A disease or condition specified in this column in relation to Chlortetracycline Capsules |
Oxytetracycline Injection B.P. | |
Oxytctracycline and Procaine Injection B.P. | |
Calcium Di-Oxytetracycline .......... | A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years |
Oxytetracycline Paediatric Drops | |
Pancreatin B.P. .................. | Fibrous disease of the pancreas |
Pancreatin Enzyme 4, U.S.N.F. XI. | Pancreatico-duodenectomy |
Pancreatic steatorrhea |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to lite persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Para-Aminosalicylic Acid ............. | Tuberculosis |
Paramethasone Acetate ............... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Paraffin Liquid Emulsion B.P. .......... | Any disease or condition in a pensioner |
Pethidine and Levallorphan Tartrate ...... | Obstetrical use |
Phenoxymethylpenicillin B.P., Oral Suspension | Any disease or condition in a child under the age of twelve years |
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension | |
Phenoxymethylpenicillin Calcium B.P., Oral Suspension | |
Phenoxymethylpemcillin (Hydrabamine Salt), Oral Suspension | |
Phenoxymethylpenicillin Potassium B.P., Oral Suspension | |
Benzylpenicillin B.P., with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. | Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
Phenytoin Sodium B.P., Oral Suspension | Any disease or condition in a child under the age of twelve years |
Phytomenadione Injection B.P. ......... | Antidote to anticoagulants |
Piperazine Citrate B.P., Elixir .......... | Any disease or condition in a child under the age of twelve years |
Polydimethylsiloxanes ............... | Ileostomy or colostomy conditions |
Prednisolone Disodium Phosphate ....... | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report |
Prednisolone Tablets B.P. ............. | With the written authority of the Director-General— |
| Anaemia, acquired haemolytic |
| Adrenogenital syndrome |
| Cranial arteritis |
| Cushing's syndrome, including hyperadrenocorticalism |
| Dermatitis, acute exfoliative, associated with drug therapy |
| Dermatomyositis |
| Encephalomyelitis |
| Guillain—Barre syndrome |
| Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis |
| Hansen's disease |
| Hepatitis, progressive or continuing, proven by biopsy or biochemistry |
| Hodgkins disease |
| Idiopathic hypercalcaemia |
| Keratoplasty |
| The leukaemias |
| Lymphosarcoma and follicular lymphoma |
| Metastatic breast carcinoma |
| Nephritis, type II. |
| Nephrosis or nephrotic syndrome |
| Neuro-myelitis optica |
| Nodular non-suppurative panniculitis (Christian-Weber disease) |
| Optic neuritis following removal of tumour of the brain |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part. VII. of the Act. |
| Panhypopituitarism |
| Pemphigus |
| Periarteritis nodosa |
| Progressive transverse myelitis |
| Pseudohermaphroditism |
| Purpura, Henoch's |
| Purpura, thrombocytopenic |
| Reticulum cell sarcoma |
| Rheumatic carditis, acute |
| Salaam convulsions and hypsarrythmia |
| Sarcoidosis |
| Sclerederma |
| Severe reactions of the skin and mucosa following X-ray therapy |
| Splenic neutropena and agranulocytosis |
| Status asthmaticus |
| Steroid therapy prior to operation in patients under steroid therapy |
| Stevens—Johnson syndrome |
| Still's disease in a child under the age of sixteen years |
| Sympathetic ophthalmitis |
| Systemic lupus erythematosus |
| Temporal arteritis |
| Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases |
| Ulcerative colitis proven by sigmoidoscopy or radiological report |
| Uveitis, posterior |
Methyl Prednisolone ............. | With the written authority of the Director General, a disease or condition specified in this column in relation to Prednisolone Tablets |
Prednisolone Acetate B.P. ...... | With the written authority or the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. | |
Prednisolone Sodium Hemisuccinate | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Prednisone Tablets B.P. ........... | With the written authority of the Director-General— |
| A disease or condition specified in this column in relation to Cortisone Injection |
| Nodular non-suppurative panniculitis (Christian-Weber disease) |
Prednisone B.P. with Magnesium Trisilicato B.P. and Dried Aluminium Hydroxide Gel. B.P. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Progesterone Injection B.P. ........ | Habitual abortion |
Promethazine Hydrochloride B.P., Elixir | Any disease or condition in a child under the age of twelve years |
Prophenpyridamine Malcate, Oral Syrup | Any disease or condition in a child under the age of twelve years |
Protoveratrines A ............... | Hypertensive crisis |
Pyrazinamide ................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Pyridine Aldoximc Mcthiodidc ...... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the poisons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Pyridostigmine Injection B.P. ....... | Myasthenia gravis |
Pyridostigmine Tablets B.P. ........ | Myasthenia gravis |
Riboflavine Tablets B.P. .......... | Any disease or condition in a pensioner |
Ristocetin .................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Salicylazosulphapyridine .......... | Ulcerative colitis |
Senna Fruit Extract .............. | Any disease or condition in a pensioner |
Sobee ....................... | With the written authority of the Director-General, galactosaemia |
Sodium Aminosalicylate B.P. | Tuberculosis |
Sodium Aminosalicylate Tablets B.P. | |
Sodium Folate ................. | Macrocytic anaemia |
| Sprue or the sprue-like syndrome |
Spiramycin ................... | Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins |
Spironolactone ................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Stilboestrol B.P. ................ | Carcinoma of the prostate |
Stilboestrol Tablets B.P. .......... | Mammary carcinoma |
| Any disease or condition in a pensioner |
Streptomycin Sulphate B.P. ........ | Bacillary dysentary that is resistant to the Sulphonamides |
| Brucellosis |
| Chancroid |
| Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
| Friedlander bacillus infections |
| Haemophilus influenzae infections |
| Plague |
| Pseudomonas pyocyaneus infections |
| Rat-bite fever (Streptobacillus moniliformis) |
| Salmonella infections |
| Surgical conditions of the bowel (pre-operative and post-operative) |
| Surgical conditions of the thoracic organs |
| Tuberculosis |
| Tularaemia |
| Urinary tract infections that are resistant to the Sulphonamides |
Streptomycin Sulphate Injection B.P. .. | A disease or condition specified in this column in relation to Streptomycin Sulphate |
Streptomycin Sulphate B.P. with Benzyl-penicillin Sodium. B.P. | Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
Sulphadimethoxine Suspension |
|
Sulphadimidine Oral Suspension | Any disease or condition in a child under the age of twelve years |
Sulphaphenazole Syrup ......... |
|
Surgical cement ................ | Ileostomy or colostomy conditions |
Sustanon .................. |
|
Testosterone Implants B.P. ...... | Castration syndrome |
Testosterone Oenanthate .......... | Mammary carcinoma |
Testosterone Propionate Injection B.P. | Castration syndrome |
Testosterone Propionate B.P. | Kline felter Rcifenstein Albright syndrome |
Mcthyltestosterone Tablets B.P. | Mammary carcinoma |
Tetracycline with a buffering agent and Amphotericin B | A disease or condition specified in this column in relation to Tetracycline with Nystatin in a child under the age of twelve years |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Tetracycline Capsules B.P. ....... | A disease or condition specified in this column in relation to Chlortetracycline Capsules |
Tetracycline Tablets B.P. ........ | |
Tetracycline and Procaine Injections B.P. | |
Tetracycline Hydrochloride B.P. with a buffering agent—Capsules | |
Tetracycline Injection B.P. .. | |
Tetracycline with Oleandomycin Capsules | |
Pyrrolidino-Methyl-Tetracycline | |
Tetracycline with a buffering agent— Oral Suspension | A disease or condition, specified in this column in relation to Chloretracycline capsules, in a child under the age of twelve years |
Tetracycline with a buffering agent— Paediatric Drops | |
Tetracycline with Oleandomycin—Oral Suspension | |
Tetracycline with Oleandomycin —Paediatric Drops | |
Tetracycline with Nystatin .......... | Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis |
| A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules |
Thcnalidine Tartrate Syrup .......... | Any disease or condition in a child under the age of twelve years |
Thyrotropin .................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Tragacanth B.P., Powder ........... | Ileostomy or colostomy conditions |
Triamcinolone .................. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Triethylcne Thiosphosphoramide ...... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Tretamine ..................... | Malignant lymphoma and related conditions |
Trifluoperazine .................. | Any disease or condition in a pensioner |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride or Trifluoperazine |
Trimetaphan Camphorsulphonate ...... | Hypotensive for anaesthesia |
Triprolidine Hydrochloride, Elixir ..... | Any disease or condition in a child under the age of twelve years |
Vancomycin Hydrochloride ......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (Including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Veriloid ...................... | Hypertensive crisis |
Viomycin Sulphate ............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D | Any disease or condition in a pensioner |
Vitamin A Oral Tablets ............. | Any disease or condition in a pensioner |
Concentrated Vitamin A Solution B.P. | Any disease or condition in a child under the age of twelve years or in a pensioner |
Concentrated Vitamin A and D Solution B.P. | |
Concentrated Vitamin D Solution B.P. | Tetany |
| Any disease or condition in a child under the age of twelve years or in a pensioner |
Vitamin K ..................... | As an antidote to anticoagulants |
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.